polatuzumab vedotin patient information

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
polatuzumab vedotin patient information	1.91	0.8	300	5	39
polatuzumab	0.36	0.6	2812	17	11
vedotin	1.98	0.2	5100	13	7
patient	0.17	0.8	5612	68	7
information	1.77	0.1	5225	31	11

Keyword	CPC	PCC	Volume	Score
polatuzumab vedotin patient information	0.38	0.6	9059	62
polatuzumab vedotin j code	1.75	0.9	3101	37
polatuzumab vedotin mechanism of action	1.7	0.2	2281	31
polatuzumab vedotin fda label	1.57	0.7	7882	88
cost and availability of polatuzumab vedotin	1.64	0.2	3075	96
polatuzumab vedotin package insert	1.71	0.4	8424	23
polatuzumab vedotin fda approval	1.77	0.8	7097	57
polatuzumab vedotin in previously untreated	0.41	0.1	997	15
polatuzumab vedotin fda approval history	1.53	0.3	8101	25
polatuzumab vedotin side effects	1.01	0.2	4093	6
polatuzumab vedotin-piiq	1.22	0.6	6841	29
polatuzumab vedotin scheda tecnica	0.31	0.6	6655	77
polatuzumab vedotin-piiq j code	1.75	0.3	3644	86
polatuzumab vedotin bendamustine rituximab	1.75	0.9	146	76
polivy polatuzumab vedotin-piiq	1.5	0.6	5285	54
polatuzumab patient information uk	1.33	0.4	7346	1
polatuzumab vedotin-piiq package insert	0.54	0.9	939	61
polatuzumab vedotin-piiq other names	1.02	1	4114	90
telisotuzumab vedotin mechanism of action	1.53	0.1	7519	85
vedolizumab patient information leaflet	1.64	0.8	6344	68
telisotuzumab-vedotin	1.87	0.6	304	62
telisotuzumab vedotin fda approval	1.27	0.1	7618	40